Our Three-Pillar Therapeutic Framework
The integral approach to severe asthma management is built upon three interconnected therapeutic pillars, each selected for its specific role in addressing different aspects of the condition's pathophysiology and clinical presentation.
Core Regenerative Therapy
Umbilical cord-derived mesenchymal stem cells (UC-MSCs) serve as the foundation of our protocol. These cells are administered through minimally invasive techniques and are recognized in the medical literature for their immunomodulatory properties and potential to influence tissue microenvironment.
Learn MoreSupportive Physical Therapy
A structured pulmonary rehabilitation program designed to improve respiratory muscle function, enhance breathing mechanics, and increase exercise tolerance. This component addresses the functional limitations often associated with severe asthma.
Explore ProtocolsNutritional Medicine Support
Evidence-based nutritional interventions aimed at modulating inflammatory pathways and supporting overall respiratory health. This pillar complements the regenerative process by addressing systemic factors that may influence asthma pathophysiology.
Get Your Personalized PlanTherapeutic Rationale and Mechanism
The selection of umbilical cord-derived mesenchymal stem cells is based on their documented immunomodulatory capabilities. These cells secrete various bioactive molecules that may influence the local inflammatory environment in respiratory tissues.
When integrated with physical therapy, which aims to improve respiratory mechanics and functional capacity, and nutritional medicine targeting systemic inflammation, this approach represents a comprehensive strategy rather than a singular intervention.
The minimally invasive administration techniques are chosen to maximize cellular delivery while minimizing patient discomfort and procedural risk, consistent with contemporary medical practice standards for cellular therapies.
Meet Our Doctors →Scientific Illustration
of Mechanism
Clinical Eligibility Considerations
Our clinical team evaluates several factors when considering patients for this integral therapeutic approach. The following represents general considerations that guide our patient assessment process:
- Documented diagnosis of severe asthma by pulmonary specialists
- Suboptimal response to conventional pharmacological management
- Comprehensive medical evaluation to assess overall health status
- Absence of contraindications to cellular therapy procedures
- Commitment to participate in all three therapeutic components
- Realistic understanding of therapeutic goals and timeframe
- Willingness to undergo necessary pre-therapy assessments
It is important to emphasize that individual eligibility determinations are made only after thorough medical evaluation and consultation with our clinical team. This approach is not appropriate for all patients with asthma, and traditional medical management remains the standard of care for most individuals.
Patients considering this approach should maintain their current asthma management regimen until a complete evaluation and therapeutic plan has been established with our medical team.